Losartan Potassium Tablet, Film Coated
Product Images NDC 51655-828

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 51655-828). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 828 26 Master Bottle Label Approval Rev A 02 22)

Losartan Potassium Tablets (100mg) are Rx only medication sold in a pack of 90 tablets. The medication must be stored in its original container at a temperature between 20°- 25°C (68°-77°F). Keep the medication out of children's reach and the container tightly closed. The medication is repackaged by Northwind Pharmaceuticals and contains Indianopolis, IN 46203 in its composition. DOSAGE: See package insert, and the product should be protected from light. The product LOT number is 0000000000, with an expiration date of 00/00/0000, and a GTIN of 00351655828267.*

FDA Label Image

Losartanaddress2 (Losartanaddress2)

FDA Label Image

Losartanfigure1 (Losartanfigure1)

FDA Label Image

Losartanfigure2 (Losartanfigure2)

The given text is showing the results of a study where the adjusted risk reduction is 26% with a p-value of 0.001. The data seems to be presented across different study months and indicates the percentage of patients with first-line or fatal stroke.*

FDA Label Image

Losartanfigure3 (Losartanfigure3)

This appears to be a table or figure related to medical data and demographic subsets. It includes information on a primary endpoint composite stroke and fatal/non-fatal events within different demographic groups. The data seems to compare the effectiveness of two different treatments, Losartan and Atancll. However, the text is not very clear and contains a lot of mistakes, making it difficult to understand the specifics of the study. Therefore, a proper description cannot be generated.*

FDA Label Image

Losartanfigure4 (Losartanfigure4)

The text appears to be a table with headers "Risk Reduction", "% Patents with Event" and "Months". The table has a single row of data where Risk Reduction is "0022", % Patents with Event is "18.1%", and Months is not available.*

FDA Label Image

Losartanstructure (Losartanstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.